1. OMICS Group Contact us at: contact.omics@omicsonline.org OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 400 leading-edge peer reviewed Open Access Journals and organizes over 300 International Conferences annually all over the world. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities that ensure a rapid, quality and quick review process. OMICS Group signed an agreement with more than 1000 International Societies to make healthcare information Open Access.

2. OMICS Group welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible way. OMICS Journals are poised in excellence by publishing high quality research. OMICS Group follows an Editorial Manager® System peer review process and boasts of a strong and active editorial board. Editors and reviewers are experts in their field and provide anonymous, unbiased and detailed reviews of all submissions. The journal gives the options of multiple language translations for all the articles and all archived articles are available in HTML, XML, PDF and audio formats. Also, all the published articles are archived in repositories and indexing services like DOAJ, CAS, Google Scholar, Scientific Commons, Index Copernicus, EBSCO, HINARI and GALE. For more details please visit our website: http://omicsonline.org/Submitmanuscript.php http://omicsonline.org/Submitmanuscript.php OMICS Journals are welcoming Submissions

3. Maroun Miled Abou-Jaoude, MD Professor of surgery Lebanese University Lebanon Editor Journal of Transplantation Technologies & Research

4. Biography: Graduated in medicine from St-Joseph University - Lebanon 1984, than trained in General Surgery, Laparoscopic Surgery and Multi-Organ Transplant Surgery in Canada FRCS©, FACS, FICS and American board of Surgery Professor of surgery at both the Lebanese University and Balamand, University - Lebanon Hold a total of 13 international and 3 national degrees and diplomas. Recipient of 8 national and international awards Member of more than 26 international and national academic and professional societies and member of the editorial board of “International Surgery” Journal Scientific achievements: More than 45 scientific publications, 2 book reviews, more than 100 medical abstracts and more than 130 medical presentations in national and international medical meetings Involved as a Fellow in London, Canada, in performing the first successful combined liver-small bowel transplantation in the world. November 1988 I succeeded to perform the first living-related lung transplant in the Middle-East August 1997 at St-Georges Hospital, Beirut, Lebanon combined Lebanese-French team. I succeeded to perform the first combined Kidney-Pancreas transplant in Lebanon November 1999 at St-Georges Hospital, Beirut, Lebanon.

5. Research Interest:  Cardiothoracic Surgery  Lung Transplantation.

6. Pulmonary Transplantation: Pulmonary Transplantation is a technique of transferring lung from a healthy individual to a patient with end-stage lung disease.

7. Pulmonary Transplantation is the ultimate treatment of choice for patients with end stage lung disease as it offers better long term survival and quality of life compared to therapeutics.

8. Criteria for Lung Donor: There should not be any evidence of preexisting pulmonary diseases Donor should not contain any transmissible diseases.

9. Donor should have the relative or similar blood group. They should have excellent medical condition with normal lung function. Donor should not have the age above 70 years.

10. The first human pulmonary transplant was performed in a patient with bronchogenic carcinoma who died because of renal failure after 18 days of pulmonary transplantation in 1963.

11. Pulmonary transplantation is the therapeutic option for patients with severe pulmonary disease who are refractory to medical therapy.

12. The most common form of interstitial lung disease of unknown origin is idiopathic pulmonary fibrosis.

13. Pulmonary transplantation has become one of the treatments of choice for patients with advanced idiopathic pulmonary fibrosis.

14. Pulmonary transplant has been the preferable treatment for above 40 years for several end-stage respiratory diseases.

15. Blood loss during pulmonary transplantation is a most complex issue affected not only by the clotting reserve

16. but also by operative methods and presence of other factors like portal hypertension which may play a vital role in the bleeding tendency of the patients.

17. Although pulmonary transplantation is the most favorable method, it should be considered for patients with progressive lung disease only when no other options are available.

18. Transplantation Technologies & Research Related Journals  Hair: Therapy & Transplantation  Liver: Disease & Transplantation  Surgery: Current Research  Hair: Therapy & Transplantation  Liver: Disease & Transplantation  Surgery: Current Research

19.  4th International Conference on Surgery and Anesthesia  World Summit on Pediatric Cardiology and Cardiac Surgery  4th International Conference on Surgery and Anesthesia  World Summit on Pediatric Cardiology and Cardiac Surgery Transplantation Technologies & Research Related Conferences

20. OMICS Group Open Access Membership OMICS publishing Group Open Access Membership enables academic and research institutions, funders and corporations to actively encourage open access in scholarly communication and the dissemination of research published by their authors. For more details and benefits, click on the link below: http://omicsonline.org/membership.php OMICS publishing Group Open Access Membership enables academic and research institutions, funders and corporations to actively encourage open access in scholarly communication and the dissemination of research published by their authors. For more details and benefits, click on the link below: http://omicsonline.org/membership.php